Kerlix Gauze Study in a Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients
Kerlix AMD Gauze Study In A Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients
1 other identifier
interventional
108
1 country
1
Brief Summary
The purpose of this study is to determine whether Kerlix AMD gauze will decrease the incidence of healthcare associated infections in burn patients. Kerlix AMD gauze will be applied to all patients with open wounds admitted to the burn unit during the prospective portion of the study. All consenting patients will be assessed for hospital associated infections and outcomes. We hypothesis that burn patients will have a decreased number of hospital associated infections compared to historical controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2008
CompletedFirst Posted
Study publicly available on registry
April 11, 2008
CompletedStudy Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedOctober 12, 2018
August 1, 2009
10 months
April 7, 2008
October 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary endpoint is the incidence of healthcare associated infections in the study of the acute burn population when using Kerlix AMD gauze as compared to that in matched historical controls when using standard, non-impregnated gauze.
2 years
Secondary Outcomes (7)
Compare the incidence of wound infections between the acute burn study patients and the matched historical control patients.
2 years
Compare the incidence of healthcare associated infections in the unit when using Kerlix AMD to the previous year using standard gauze. Epidemiology infection rates will be used to compare the incidence of infections.
2 years
Compare the presence of pathogenic organisms on weekly wound swabs between the acute burn study patients and the matched historical control patients.
2 years
Compare the nasal MSSA/MRSA colonization between the acute burn study patients and the matched historical control patients.
2 years
Compare the incidence of rectal VRE colonization between the acute burn study patients and the matched historical control patients.
2 years
- +2 more secondary outcomes
Study Arms (1)
PB
EXPERIMENTALAll patients admitted to the burn unit during the prospective portion (interventional portion) of the study who have open wounds will have Kerlix AMD applied to their wounds; only those patients consenting to the study will have data abstracted.
Interventions
Use Kerlix AMD gauze as the wound dressing for the entire burn unit
Eligibility Criteria
You may qualify if:
- admitted to the burn unit with a burn or open wound and anticipated to have a length of stay greater than 48 hours
You may not qualify if:
- pregnant or nursing women
- wound is considered unsuitable for study dressings as determined by primary physician
- use of Dakin's solution on wound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lucy A Wibbenmeyerlead
- Medtronic - MITGcollaborator
Study Sites (1)
The University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
Related Publications (10)
Appelgren P, Bjornhagen V, Bragderyd K, Jonsson CE, Ransjo U. A prospective study of infections in burn patients. Burns. 2002 Feb;28(1):39-46. doi: 10.1016/s0305-4179(01)00070-5.
PMID: 11834328BACKGROUNDTaylor GD, Kibsey P, Kirkland T, Burroughs E, Tredget E. Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit. Burns. 1992 Aug;18(4):332-5. doi: 10.1016/0305-4179(92)90158-q.
PMID: 1418512BACKGROUNDWibbenmeyer L, Danks R, Faucher L, Amelon M, Latenser B, Kealey GP, Herwaldt LA. Prospective analysis of nosocomial infection rates, antibiotic use, and patterns of resistance in a burn population. J Burn Care Res. 2006 Mar-Apr;27(2):152-60. doi: 10.1097/01.BCR.0000203359.32756.F7.
PMID: 16566558BACKGROUNDWurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nosocomial infections in a burn intensive care unit. Burns. 1995 May;21(3):181-4. doi: 10.1016/0305-4179(95)80005-9.
PMID: 7794498BACKGROUNDNational Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. Am J Infect Control. 2001 Dec;29(6):404-21. doi: 10.1067/mic.2001.119952. No abstract available.
PMID: 11743489BACKGROUNDStone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control. 2005 Nov;33(9):501-9. doi: 10.1016/j.ajic.2005.04.246.
PMID: 16260325BACKGROUNDMayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003 Aug 15;37(4):543-50. doi: 10.1086/376993. Epub 2003 Jul 30.
PMID: 12905139BACKGROUNDMotta GJ, Milne CT, Corbett LQ. Impact of antimicrobial gauze on bacterial colonies in wounds that require packing. Ostomy Wound Manage. 2004 Aug;50(8):48-62.
PMID: 15356368BACKGROUNDMotta GJ, Trigilia D. The effect of an antimicrobial drain sponge dressing on specific bacterial isolates at tracheostomy sites. Ostomy Wound Manage. 2005 Jan;51(1):60-2, 64-6.
PMID: 15695836BACKGROUNDGarner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988 Jun;16(3):128-40. doi: 10.1016/0196-6553(88)90053-3.
PMID: 2841893BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucy A Wibbenmeyer, MD
The University of Iowa Hospitals & Clinics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
April 7, 2008
First Posted
April 11, 2008
Study Start
August 1, 2008
Primary Completion
June 1, 2009
Study Completion
January 1, 2011
Last Updated
October 12, 2018
Record last verified: 2009-08
Data Sharing
- IPD Sharing
- Will not share